Michela Leocadi, PhD, research fellow at UCL Queen Square Institute of Neurology, discussed new longitudinal data showing early functional connectivity changes in HD gene carriers years before clinical motor diagnosis.
|Videos|January 29, 2018
Weight Loss and Parkinson Disease
Author(s)Bobby Lazzara, MD
An incident, population-based prospective cohort study examined weight changes over time in patients with Parkinson disease.
Advertisement
An incident, population-based prospective
The study results showed weight loss occurring within 1 year of diagnosis was independently associated with an increased risk of dependency, dementia, and death. The authors concluded that dietary interventions early after diagnosis may improve outcomes.
Advertisement
Related to this article
In a phase 4 randomized controlled trial, opicapone failed to demonstrate statistical superiority over placebo for reducing fluctuation-related pain in patients living with Parkinson disease.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 11, 2026.
A newly launched global phase 3 trial will compare once-daily trientine to D-penicillamine as a first-line treatment for patients with Wilson disease, a rare genetic disorder.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves UX111, First Gene Therapy for Pediatric Sanfilippo Syndrome Type A
2
Exploring the Unmet Needs in CIDP
3
Previewing Advancements in Hypersomnia Diagnosis and Treatment
4
RIPK1 Inhibitor Fails to Slow Functional Decline in Phase 2 ALS Trial
5